Tessellate Bio

R&D/Manufacturing

Membership category
Corporate

4 More London, Riverside, London, SE1 2AU, United Kingdom

Tessellate Bio at a glance

The next-generation Synthetic Lethality precision oncology company

About Tessellate Bio

Tessellate BIO is a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches. Its lead program targets the DNA damage response (DDR) and in particular cancers that depend on Alternative Lengthening of Telomeres (ALT). The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populations. The company is backed by leading venture firms, BioGeneration Ventures (BGV) and Forbion and has a world-class leadership team with proven experience as entrepreneurs and deep expertise in drug discovery and precision oncology.

Articles Tessellate Bio has contributed to